News

Find News

Filter articles

Showing 1 to 10 of 3777 results

Blank Rome hires new patent agent for Texas office

US26-01-2023Muireann Bolger

Blank Rome has brought in patent agent Joseph Jackson to the firm’s IP and Technology practice group in Houston.

BMS sues AstraZeneca for infringing cancer treatment drug

US26-01-2023Liz Hockley

US pharma giant says competitor’s drug Imjudo violates two patents | BMS’ blockbuster was first to use checkpoint inhibitors, says complaint.

FTC targets ‘Pharma Bro’ Martin Shkreli over start-up

US24-01-2023Muireann Bolger

Commission holds that the convicted former pharma head may have violated his life-long ban from working in the life sciences industry | Shkreli is already convicted of conspiring to illegally increase the price of a life-saving drug.

Report: Market for anti-counterfeit drugs packaging to hit $191bn by 2030

International24-01-2023Liz Hockley

New study examines industry by product, application and region | China, Germany and India predicted to see the largest growth.

Jazz Pharma’s medical cannabis unit seeks to block generic

US19-01-2023Liz Hockley

UK-based cannabidiol lab sues firms behind proposed ANDA | Feud centres on a cannabis treatment for epilepsy.

Cohausz & Florack hires senior technical duo

International19-01-2023Staff Writer

Cohausz & Florack has added two new partners to the team to further expand the firm’s IP expertise in key technical areas.

Withers hires senior duo from Brown Rudnick to Boston office

US12-01-2023Tom Phillips

Leader of Brown Rudnik’s IP practice moves to US office of London firm | Boston office continues growth.

L’Oreal prevails in anti-aging treatment clash

US12-01-2023Muireann Bolger

Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.

Drugs to Watch report: 15 blockbusters for 2023

International12-01-2023Liz Hockley

Clarivate study highlights treatments with blockbuster potential | IV, Parkinson’s disease, Crohn’s disease, alopecia, multiple myeloma and breast cancer make the list | Nine blockbusters from China also predicted.

Gilead avoids $1.2bn patent clash at SCOTUS

US10-01-2023Muireann Bolger

Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.

Showing 1 to 10 of 3777 results

LSIPR